Cargando…
Securin Enhances the Anti-Cancer Effects of 6-Methoxy-3-(3′,4′,5′-Trimethoxy-Benzoyl)-1H-Indole (BPR0L075) in Human Colorectal Cancer Cells
BPR0L075 [6-methoxy-3-(3′,4′,5′-trimethoxy-benzoyl)-1H-indole] is a novel anti-microtubule drug with anti-tumor and anti-angiogenic activities in vitro and in vivo. Securin is required for genome stability, and is expressed abundantly in most cancer cells, promoting cell proliferation and tumorigene...
Autores principales: | Tseng, Ho-Hsing, Chuah, Qiu-Yu, Yang, Pei-Ming, Chen, Chiung-Tong, Chao, Jung-Chi, Lin, Ming-Der, Chiu, Shu-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338557/ https://www.ncbi.nlm.nih.gov/pubmed/22563433 http://dx.doi.org/10.1371/journal.pone.0036006 |
Ejemplares similares
-
Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts
por: Liu, Li, et al.
Publicado: (2012) -
An Antimitotic and Antivascular Agent BPR0L075 Overcomes Multidrug Resistance and Induces Mitotic Catastrophe in Paclitaxel-Resistant Ovarian Cancer Cells
por: Wang, Xiaolei, et al.
Publicado: (2013) -
5-Methoxy-1-(3,4,5-trimethoxyphenyl)-1H-indole
por: Monroe, Thomas Blake, et al.
Publicado: (2010) -
Radiation-induced senescence in securin-deficient cancer cells promotes cell invasion involving the IL-6/STAT3 and PDGF-BB/PDGFR pathways
por: Yu, Yi-Chu, et al.
Publicado: (2013) -
3,4,5-Trimethoxy-N-(2-methoxyphenyl)benzamide
por: Saeed, Aamer, et al.
Publicado: (2009)